Current Ratio of Summit Therapeutics Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Summit Therapeutics Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • Summit Therapeutics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 669%, a 39% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 669% +187% +39% 30 Sep 2025
Q2 2025 814% +516% +173% 30 Jun 2025
Q1 2025 585% +122% +26% 31 Mar 2025
Q4 2024 532% -0.24% -0.04% 31 Dec 2024
Q3 2024 482% -253% -34% 30 Sep 2024
Q2 2024 298% -1198% -80% 30 Jun 2024
Q1 2024 463% -810% -64% 31 Mar 2024
Q4 2023 532% -510% -49% 31 Dec 2023
Q3 2023 735% +220% +43% 30 Sep 2023
Q2 2023 1496% +1058% +241% 30 Jun 2023
Q1 2023 1273% +821% +182% 31 Mar 2023
Q4 2022 1042% +731% +235% 31 Dec 2022
Q3 2022 515% +198% +62% 30 Sep 2022
Q2 2022 438% +148% +51% 30 Jun 2022
Q1 2022 452% +195% +76% 31 Mar 2022
Q4 2021 311% 31 Dec 2021
Q3 2021 317% 30 Sep 2021
Q2 2021 291% 30 Jun 2021
Q1 2021 257% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.